These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15582420)

  • 1. Heterocyclic sulfoxide and sulfone inhibitors of fatty acid amide hydrolase.
    Du W; Hardouin C; Cheng H; Hwang I; Boger DL
    Bioorg Med Chem Lett; 2005 Jan; 15(1):103-6. PubMed ID: 15582420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.
    Boger DL; Sato H; Lerner AE; Hedrick MP; Fecik RA; Miyauchi H; Wilkie GD; Austin BJ; Patricelli MP; Cravatt BF
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5044-9. PubMed ID: 10805767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
    Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
    Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A; Hanekamp W; Lehr M
    Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
    Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
    J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents.
    McAllister LA; Montgomery JI; Abramite JA; Reilly U; Brown MF; Chen JM; Barham RA; Che Y; Chung SW; Menard CA; Mitton-Fry M; Mullins LM; Noe MC; O'Donnell JP; Oliver RM; Penzien JB; Plummer M; Price LM; Shanmugasundaram V; Tomaras AP; Uccello DP
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6832-8. PubMed ID: 23046961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
    Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
    Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.
    Ezzili C; Mileni M; McGlinchey N; Long JZ; Kinsey SG; Hochstatter DG; Stevens RC; Lichtman AH; Cravatt BF; Bilsky EJ; Boger DL
    J Med Chem; 2011 Apr; 54(8):2805-22. PubMed ID: 21428410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
    Fowler CJ; Jonsson KO; Tiger G
    Biochem Pharmacol; 2001 Sep; 62(5):517-26. PubMed ID: 11585048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase.
    Keith JM; Jones WM; Pierce JM; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Scott BP; Wilson SJ; Luo L; Wennerholm ML; Chang L; Brown SM; Rizzolio M; Rynberg R; Chaplan SR; Breitenbucher JG
    Bioorg Med Chem Lett; 2014 Feb; 24(3):737-41. PubMed ID: 24433863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macamides and their synthetic analogs: evaluation of in vitro FAAH inhibition.
    Wu H; Kelley CJ; Pino-Figueroa A; Vu HD; Maher TJ
    Bioorg Med Chem; 2013 Sep; 21(17):5188-97. PubMed ID: 23891163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitution.
    Boger DL; Miyauchi H; Hedrick MP
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1517-20. PubMed ID: 11412972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.
    Vandevoorde S
    Curr Top Med Chem; 2008; 8(3):247-67. PubMed ID: 18289091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors.
    Deplano A; Cipriano M; Moraca F; Novellino E; Catalanotti B; Fowler CJ; Onnis V
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):562-576. PubMed ID: 30688118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of fatty acid amide hydrolase inhibition by potent alpha-ketoheterocycle derivatives from Monte Carlo simulations.
    Guimarães CR; Boger DL; Jorgensen WL
    J Am Chem Soc; 2005 Dec; 127(49):17377-84. PubMed ID: 16332087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolase.
    Keith JM; Jones W; Pierce JM; Seierstad M; Palmer JA; Webb M; Karbarz M; Scott BP; Wilson SJ; Luo L; Wennerholm M; Chang L; Rizzolio M; Rynberg R; Chaplan S; Guy Breitenbucher J
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127463. PubMed ID: 32784090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
    Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Uracil Derivatives as Potent Inhibitors of Fatty Acid Amide Hydrolase.
    Qiu Y; Zhang Y; Li Y; Ren J
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26901181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid amide hydrolase inhibitors--progress and potential.
    Khanna IK; Alexander CW
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.